Search Results - "Daheng He"

Refine Results
  1. 1

    p300/CBP inhibition enhances the efficacy of programmed death-ligand 1 blockade treatment in prostate cancer by Liu, Jinghui, He, Daheng, Cheng, Lijun, Huang, Changkun, Zhang, Yanquan, Rao, Xiongjian, Kong, Yifan, Li, Chaohao, Zhang, Zhuangzhuang, Liu, Jinpeng, Jones, Karrie, Napier, Dana, Lee, Eun Y., Wang, Chi, Liu, Xiaoqi

    Published in Oncogene (07-05-2020)
    “…Blockade of programmed death-ligand 1 (PD-L1) by therapeutic antibodies has shown to be a promising strategy in cancer therapy, yet clinical response in many…”
    Get full text
    Journal Article
  2. 2

    Spermine synthase and MYC cooperate to maintain colorectal cancer cell survival by repressing Bim expression by Guo, Yubin, Ye, Qing, Deng, Pan, Cao, Yanan, He, Daheng, Zhou, Zhaohe, Wang, Chi, Zaytseva, Yekaterina Y., Schwartz, Charles E., Lee, Eun Y., Evers, B. Mark, Morris, Andrew J., Liu, Side, She, Qing-Bai

    Published in Nature communications (26-06-2020)
    “…Dysregulation of polyamine metabolism has been linked to the development of colorectal cancer (CRC), but the underlying mechanism is incompletely…”
    Get full text
    Journal Article
  3. 3

    Combating acquired resistance to MAPK inhibitors in melanoma by targeting Abl1/2-mediated reactivation of MEK/ERK/MYC signaling by Tripathi, Rakshamani, Liu, Zulong, Jain, Aditi, Lyon, Anastasia, Meeks, Christina, Richards, Dana, Liu, Jinpeng, He, Daheng, Wang, Chi, Nespi, Marika, Rymar, Andrey, Wang, Peng, Wilson, Melissa, Plattner, Rina

    Published in Nature communications (29-10-2020)
    “…Metastatic melanoma remains an incurable disease for many patients due to the limited success of targeted and immunotherapies. BRAF and MEK inhibitors reduce…”
    Get full text
    Journal Article
  4. 4

    Inhibition of Fatty Acid Synthase Upregulates Expression of CD36 to Sustain Proliferation of Colorectal Cancer Cells by Drury, James, Rychahou, Piotr G, He, Daheng, Jafari, Naser, Wang, Chi, Lee, Eun Y, Weiss, Heidi L, Evers, Bernard Mark, Zaytseva, Yekaterina Y

    Published in Frontiers in oncology (31-07-2020)
    “…Fatty acid synthase, a key enzyme of lipogenesis, is an attractive therapeutic target in cancer. The novel fatty acid synthase inhibitor, TVB-3664, shows…”
    Get full text
    Journal Article
  5. 5

    Single-cell analysis identifies PLK1 as a driver of immunosuppressive tumor microenvironment in LUAD by Kong, Yifan, Li, Chaohao, Liu, Jinpeng, Wu, Sai, Zhang, Min, Allison, Derek B, Hassan, Faisal, He, Daheng, Wang, Xinyi, Mao, Fengyi, Zhang, Qiongsi, Zhang, Yanquan, Li, Zhiguo, Wang, Chi, Liu, Xiaoqi

    Published in PLoS genetics (17-06-2024)
    “…PLK1 (Polo-like kinase 1) plays a critical role in the progression of lung adenocarcinoma (LUAD). Recent studies have unveiled that targeting PLK1 improves the…”
    Get full text
    Journal Article
  6. 6

    Innate immune activation by checkpoint inhibition in human patient-derived lung cancer tissues by Fan, Teresa Wm, Higashi, Richard M, Song, Huan, Daneshmandi, Saeed, Mahan, Angela L, Purdom, Matthew S, Bocklage, Therese J, Pittman, Thomas A, He, Daheng, Wang, Chi, Lane, Andrew N

    Published in eLife (18-08-2021)
    “…Although Pembrolizumab-based immunotherapy has significantly improved lung cancer patient survival, many patients show variable efficacy and resistance…”
    Get full text
    Journal Article
  7. 7

    Upregulation of CD36, a Fatty Acid Translocase, Promotes Colorectal Cancer Metastasis by Increasing MMP28 and Decreasing E-Cadherin Expression by Drury, James, Rychahou, Piotr G, Kelson, Courtney O, Geisen, Mariah E, Wu, Yuanyuan, He, Daheng, Wang, Chi, Lee, Eun Y, Evers, B Mark, Zaytseva, Yekaterina Y

    Published in Cancers (05-01-2022)
    “…Altered fatty acid metabolism continues to be an attractive target for therapeutic intervention in cancer. We previously found that colorectal cancer (CRC)…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Phosphorylation of AHR by PLK1 promotes metastasis of LUAD via DIO2-TH signaling by Li, Chaohao, Allison, Derek B, He, Daheng, Mao, Fengyi, Wang, Xinyi, Rychahou, Piotr, Imam, Ibrahim A, Kong, Yifan, Zhang, Qiongsi, Zhang, Yanquan, Liu, Jinghui, Wang, Ruixin, Rao, Xiongjian, Wu, Sai, Evers, B Mark, Shao, Qing, Wang, Chi, Li, Zhiguo, Liu, Xiaoqi

    Published in PLoS genetics (21-11-2023)
    “…Metastasis of lung adenocarcinoma (LUAD) is a major cause of death in patients. Aryl hydrocarbon receptor (AHR), an important transcription factor, is involved…”
    Get full text
    Journal Article
  10. 10

    Latexin regulates sex dimorphism in hematopoiesis via gender-specific differential expression of microRNA 98-3p and thrombospondin 1 by Cui, Xiaojing, Zhang, Cuiping, Wang, Fang, Zhao, Xinghui, Wang, Shuxia, Liu, Jinpeng, He, Daheng, Wang, Chi, Yang, Feng-Chun, Tong, Sheng, Liang, Ying

    Published in Cell reports (Cambridge) (28-03-2023)
    “…Hematopoietic stem cells (HSCs) have the ability to self-renew and differentiate to all blood cell types. HSCs and their differentiated progeny show sex/gender…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13

    Upregulation of Fatty Acid Synthase Increases Activity of β-Catenin and Expression of NOTUM to Enhance Stem-like Properties of Colorectal Cancer Cells by Kelson, Courtney O, Tessmann, Josiane Weber, Geisen, Mariah E, He, Daheng, Wang, Chi, Gao, Tianyan, Evers, B Mark, Zaytseva, Yekaterina Y

    Published in Cells (Basel, Switzerland) (08-10-2024)
    “…Dysregulated fatty acid metabolism is an attractive therapeutic target for colorectal cancer (CRC). We previously reported that fatty acid synthase (FASN), a…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Co‐Targeting Plk1 and DNMT3a in Advanced Prostate Cancer by Zhang, Zhuangzhuang, Cheng, Lijun, Zhang, Qiongsi, Kong, Yifan, He, Daheng, Li, Kunyu, Rea, Matthew, Wang, Jianling, Wang, Ruixin, Liu, Jinghui, Li, Zhiguo, Yuan, Chongli, Liu, Enze, Fondufe‐Mittendorf, Yvonne N., Li, Lang, Han, Tao, Wang, Chi, Liu, Xiaoqi

    Published in Advanced science (01-07-2021)
    “…Because there is no effective treatment for late‐stage prostate cancer (PCa) at this moment, identifying novel targets for therapy of advanced PCa is urgently…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Nitrogen-rich carbon-supported ultrafine MoC nanoparticles for the hydrotreatment of oleic acid into diesel-like hydrocarbons by Wang, Fei, Zhang, Wenjuan, Jiang, Jianchun, Xu, Junming, Zhai, Qiaolong, Wei, Linshan, Long, Feng, Liu, Chao, Liu, Peng, Tan, Weihong, He, Daheng

    “…[Display omitted] •Ultrafine molybdenum carbide supported on nitrogen-rich carbon (MoC/CN) are synthesized with a facile one-step route.•Molybdenum carbide…”
    Get full text
    Journal Article
  18. 18

    Downregulation of EZH2 inhibits epithelial-mesenchymal transition in enzalutamide-resistant prostate cancer by Zhang, Zhuangzhuang, Wang, Xinyi, Kim, Miyeong, He, Daheng, Wang, Chi, Fong, Ka Wing, Liu, Xiaoqi

    Published in The Prostate (01-11-2023)
    “…Androgen signaling inhibitors (ASI) have been approved for treatment of metastatic castration-resistant prostate cancer (mCRPC). However, the limited success…”
    Get full text
    Journal Article
  19. 19
  20. 20

    The PLOD2/succinate axis regulates the epithelial-mesenchymal plasticity and cancer cell stemness by Tong, Yuxin, Qi, Yifei, Xiong, Gaofeng, Li, Junyan, Scott, Timothy L, Chen, Jie, He, Daheng, Li, Linzhang, Wang, Chi, Lane, Andrew N, Xu, Ren

    “…Aberrant accumulation of succinate has been detected in many cancers. However, the cellular function and regulation of succinate in cancer progression is not…”
    Get full text
    Journal Article